At this time, the thoughts of all those involved in the EHDEN project are with those ill with COVID-19, and those who are looking after them at home or in hospitals.
Clearly, we are all affected by this evolving pandemic, and equally, the project will be impacted by it, but we will aim to mitigate this as best as practicable.
We are looking forward to working with our Data Partners and colleagues in responding to COVID-19.
Our best wishes to all, stay safe and well.
Welcome to the website of the European Health Data & Evidence Network (EHDEN), an IMI 2 consortium with 22 partners which will operate in Europe for the coming five years, 2018 – 2024.
EHDEN was launched to address the current challenges in generating insights and evidence from real-world clinical data at scale, to support patients, clinicians, payers, regulators, governments, and the pharmaceutical industry in understanding wellbeing, disease, treatments, outcomes and new therapeutics and devices.
We are pleased to announce that we’ve just launched a new course in the...
EHDEN now working with 28 Data Partners across 11 countries to harmonise clinical data across therapeutic areas including COVID-19
28 July 2020, Brussels, Belgium. Healthcare today is ever more complex, with growing expectations...
EHDEN project collaborating with the European Medicines Agency and partners to address COVID-19 in Europe
22nd July 2020, Brussels, Belgium. The Innovative Medicines Initiative (IMI) project, European Health Data...
David van Brunt Senior Research Fellow and Head, Division of Evidence and Analytics AbbVie...